Notify me when UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| Silver Point Specialty Lending Fund | Common Shares of Beneficial Interest | 16% | 3,385,455 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 31 Dec 2025 | ||||
| RNTX | Aileron Therapeutics, Inc. | Common Stock, par value $0.001 per share | 4.4% | $1,758,017 | 960,665 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 04 Nov 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|